Rifaximin
FLORA-ACS
Approved small_molecule active
Quick answer
Rifaximin for ACS - Acute Coronary Syndrome is a Approved program (small_molecule) at COLLEGIUM PHARMACEUTICAL, INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- COLLEGIUM PHARMACEUTICAL, INC
- Indication
- ACS - Acute Coronary Syndrome
- Phase
- Approved
- Modality
- small_molecule
- Status
- active